Naihan Xu
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- DNA Repair Mechanisms
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 12
- RNA Research and Splicing 10
- DNA Repair Mechanisms 7
- Ubiquitin and proteasome pathways 7
-
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 12
- Co-authors
- David A. Gillespie (5 shared papers)Yaou Zhang (48 shared papers)Lye Mun Tho (1 shared paper)Weidong Xie (37 shared papers)Yuanzhi Lao (5 shared papers)Donald C. Chang (6 shared papers)Jie He (10 shared papers)Kathy Qian Luo (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (6 papers)International Journal of Molecular Sciences (5 papers)Scientific Reports (4 papers)Autophagy (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Naihan Xu
83 papers receiving 4.4k citations
Naihan Xu's Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 1.1k
- Molecular Biology 2.8k
- Oncology 722
- Cell Biology 367
- Epidemiology 624
Countries citing papers authored by Naihan Xu
This map shows the geographic impact of Naihan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naihan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naihan Xu more than expected).
Fields of papers citing papers by Naihan Xu
This network shows the impact of papers produced by Naihan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naihan Xu. The network helps show where Naihan Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Naihan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer Hit paper breakdown → | 2010 | 986 |
| 2 | 2012 | 239 | |
| 3 | 2013 | 159 | |
| 4 | 2013 | 144 | |
| 5 | 2018 | 139 | |
| 6 | 2015 | 129 | |
| 7 | 2003 | 125 | |
| 8 | 2014 | 120 | |
| 9 | 2019 | 110 | |
| 10 | 2016 | 109 | |
| 11 | 2019 | 104 | |
| 12 | 2015 | 85 | |
| 13 | 2016 | 78 | |
| 14 | 2016 | 75 | |
| 15 | 2012 | 74 | |
| 16 | 2011 | 71 | |
| 17 | 2023 | 70 | |
| 18 | 2014 | 70 | |
| 19 | 2022 | 66 | |
| 20 | 2016 | 66 |
About Naihan Xu
Naihan Xu is a scholar working on Molecular Biology, Cancer Research, Epidemiology, Oncology and Cell Biology, having authored 83 papers that have together received 4.4k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (16 papers), Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (12 papers), RNA Research and Splicing (10 papers), DNA Repair Mechanisms (7 papers), Ubiquitin and proteasome pathways (7 papers) and Microtubule and mitosis dynamics (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Molecular Biology (2.8k citations), Oncology (722 citations), Cell Biology (367 citations) and Epidemiology (624 citations). Naihan Xu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include David A. Gillespie, Yaou Zhang, Lye Mun Tho, Weidong Xie, Yuanzhi Lao, Donald C. Chang, Jie He, Kathy Qian Luo, Yuyang Jiang and Hong‐Xi Xu. Their work appears in journals such as Biochemical and Biophysical Research Communications, International Journal of Molecular Sciences, Scientific Reports, Autophagy and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.